{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:00:27Z","timestamp":1780077627476,"version":"3.54.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000019","name":"National Hemophilia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.carrev.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T03:39:22Z","timestamp":1730259562000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trends in utilization and clinical outcomes with and without the use of distal filter wire embolic protection devices"],"prefix":"10.1016","volume":"77","author":[{"given":"Timothy G.","family":"Scully","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diem","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Oqueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin","family":"Hiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Stub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.carrev.2024.10.008_bb0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jcin.2016.01.034","article-title":"Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery","volume":"9","author":"Brilakis Emmanouil","year":"2016","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2024.10.008_bb0010","article-title":"Outcomes following percutaneous coronary intervention in saphenous vein grafts with and without embolic protection devices: a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.carrev.2024.10.008_bb0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","article-title":"Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts","volume":"105","author":"Baim","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carrev.2024.10.008_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2005.09.018","article-title":"Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial","volume":"151","author":"Halkin","year":"2006","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.carrev.2024.10.008_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.010240","article-title":"Embolic protection devices","volume":"129","author":"Bangalore","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carrev.2024.10.008_bb0030","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carrev.2024.10.008_bb0035","first-page":"73","article-title":"Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: an analysis from the British Columbia Cardiac registry","volume":"88","author":"Iqbal","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2024.10.008_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041198","article-title":"Safety and efficacy of embolic protection devices in saphenous vein graft interventions: a propensity score analysis-multicenter SVG PCI PROTECTA study","volume":"9","author":"Wa\u0144ha","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.carrev.2024.10.008_bb0045","first-page":"221","article-title":"Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts","volume":"13","author":"Hashemi-Jazi","year":"2017","journal-title":"ARYA Atheroscler"},{"issue":"5","key":"10.1016\/j.carrev.2024.10.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007636","article-title":"Contemporary use of embolic protection devices during saphenous vein graft intervention","volume":"12","author":"Valle","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.carrev.2024.10.008_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001403","article-title":"Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry","volume":"8","author":"Brennan","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.carrev.2024.10.008_bb0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jcin.2019.08.037","article-title":"Outcomes following percutaneous coronary intervention in saphenous vein grafts with and without embolic protection devices","volume":"12","author":"Shoaib","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.carrev.2024.10.008_bb0065","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.21037\/jtd-23-473","article-title":"Comparison of percutaneous coronary intervention of native coronary artery versus bypass graft in patients with prior coronary artery bypass grafting","volume":"15","author":"Yang","year":"2023","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.carrev.2024.10.008_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.hlc.2010.10.002","article-title":"Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries","volume":"20","author":"Chan","year":"2011","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.carrev.2024.10.008_bb0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2024.10.008_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.amjcard.2009.09.006","article-title":"Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions","volume":"105","author":"Hong","year":"2010","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2024.10.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.004953","article-title":"Percutaneous coronary intervention of saphenous vein graft","volume":"10","author":"Redfors","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2024.10.008_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.amjcard.2009.09.006","article-title":"Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions","volume":"105","author":"Hong","year":"2010","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2024.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.carrev.2019.01.025","article-title":"Saphenous vein graft sacrifice following native vessel PCI is safe and associated with favourable longer-term outcomes","volume":"20","author":"Wilson","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2024.10.008_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2022.11.014","article-title":"Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: rationale and design of the multicenter, randomized PROCTOR trial","volume":"257","author":"de Winter","year":"2023","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.carrev.2024.10.008_bb0105","first-page":"1120","article-title":"Role of embolic protection devices in ostial saphenous vein graft lesions","volume":"80","author":"Abdel-Karim","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2024.10.008_bb0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.0000080894.51311.0A","article-title":"Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts","volume":"108","author":"Stone","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carrev.2024.10.008_bb0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5603\/CJ.a2020.0131","article-title":"One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery","volume":"29","author":"Abdelrahman","year":"2022","journal-title":"Cardiol J"},{"issue":"4","key":"10.1016\/j.carrev.2024.10.008_bb0120","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ejcts\/ezx171","article-title":"Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12615 patients with multivessel disease\u2020","volume":"52","author":"Locker","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.carrev.2024.10.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2020.03.013","article-title":"Effect of total arterial grafting in the Arterial Revascularization Trial","volume":"163","author":"Taggart","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.carrev.2024.10.008_bb0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jocs.14169","article-title":"Total arterial revascularization strategies: a meta-analysis of propensity score-matched observational studies","volume":"34","author":"Urso","year":"2019","journal-title":"J Card Surg"},{"issue":"4","key":"10.1016\/j.carrev.2024.10.008_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcin.2019.10.028","article-title":"Retrograde chronic total occlusion percutaneous coronary intervention via saphenous vein graft","volume":"13","author":"Xenogiannis","year":"2020","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:27:49Z","timestamp":1762550869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924007061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":27,"alternative-id":["S1553838924007061"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.10.008","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in utilization and clinical outcomes with and without the use of distal filter wire embolic protection devices","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}